Pharma Mar, S.A. (PHMMF)
OTCMKTS · Delayed Price · Currency is USD
88.72
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of $1.54 billion as of February 12, 2026. Its market cap has decreased by -5.58% in one year.
Market Cap
1.54B
Enterprise Value
1.43B
Revenue
210.34M
Ranking
n/a
PE Ratio
38.69
Stock Price
$88.72
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.98B to 1.54B, a decrease of -22.17%. That is a compound annual growth rate of -2.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.54B | 2.00% |
| Dec 31, 2025 | 1.51B | 5.24% |
| Dec 31, 2024 | 1.44B | 76.17% |
| Dec 29, 2023 | 816.28M | -34.05% |
| Dec 30, 2022 | 1.24B | 5.84% |
| Dec 30, 2021 | 1.17B | -27.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |